Featured Opinions
Will Physicians Become Obsolete?
Will that target market soon become obsolete in the choice of medication and other services?
Nutraceuticals: Rich in Potential
by Marc Yates
A shift to preventative health will see nutraceuticals emerge as a growth area across mature and emerging markets.
The 4 C's of Portfolio Brand Building
Customer, Community, Category & Commitment: Building a strong portfolio brand can pay dividends.
Adapting the Commercial Process to the Evolving Healthcare Delivery Landscape
3 ideas pharma should consider in modifying their commercial approach.
AMNOG and the German Reforms: What Will Change?
We analyze recent changes in Germany's pharmaceutical legislation & implications for the industry.
Understanding the Chronic Disease Patient Journey in Emerging Markets
by Marc Yates
How can pharma companies make a positive intervention to improve sub-optimal patient journeys in emerging markets?
Information Sharers or Storytellers?
Framing the conversation to uncover the deep functional & emotional customer experience of the brand is vital says David Coleiro.
The Importance of Talent and Chemistry in New Patient-First Business Models
by Jeff Elton
What will it take to get the people chemistry right?
We took the pulse of a maturing digital health start-up industry at Techtour Healthtech Summit in Lausanne.
iPad and Tablet Use in Detailing: Where Pharma is Going Wrong
Apart from the hardware, is everyone getting the most they can out of these?
Medical Director for Ophthalmology & Neurology at Bayer, Jackie Napier, on what attracted her to pharma.
Beyond Andrology: Trends in Men’s Health in Emerging Markets
by Marc Yates
Men’s health in emerging markets is more likely to be brought about by tackling attitudes than by improving access.
Novartis Pharma's new Global Head of Diversity & Inclusion, Miriam Donaldson reveals her ambitions, values and leadership tips.
Are You Getting the Most From the New Digital Customer Journey?
In order to be successful, companies and brands need to differentiate themselves by adopting an engagement-centered orientation.
BREXIT: Is the Pharmaceutical Industry at Risk?
In or out? We investigate the potential impact on pricing.
Population Health and Its Implications for Pharma
by Rita Numerof
As healthcare delivery organizations continue to evolve, pharma must respond.
Are You Sponge Bathing Regularly?
by Kevin Dolgin
Is pharma's money really where its mouth is when it comes patient support?
Has the Pendulum of Patient Centricity Swung Too Far?
by Jill Donahue
For patient centricity to actually work for us (and for patients), there needs to be another dimension – our business needs.
Comparing the digital intensity of Pharma companies.
Mapping your Brand’s Road to Prescription
Using a brand lens to understand the needs, motivations and barriers to brand utilization across the multitude of stakeholders involved is critical to success
Bayer is trialing digital solutions to boost its Pharma future. We chat to Jessica Federer, Head of Digital Development to learn more.
Leading Marketing Excellence with Next-Generation Analytics
Many companies are not as "leading-edge" in terms of analytics as they think.